Saurabh Saha is Chief Executive Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 520,661 shares of CNTA, which is worth approximately $8.93 Million. The most recent transaction as insider was on Dec 20, 2024, when has been sold 55,000 shares (Ordinary Shares) at a price of $17.44 per share, resulting in proceeds of $959,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 521K
27.88% 3M change
36.72% 12M change
Total Value Held $8.93 Million

SAURABH SAHA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 20 2024
SELL
Open market or private sale
$959,200 $17.44 p/Share
55,000 Reduced 9.55%
520,661 Ordinary Shares
Dec 06 2024
SELL
Open market or private sale
$1,615,176 $18.46 p/Share
87,496 Reduced 13.19%
575,661 Ordinary Shares
Dec 06 2024
BUY
Exercise of conversion of derivative security
$510,976 $5.84 p/Share
87,496 Added 11.66%
663,157 Ordinary Shares
Nov 25 2024
SELL
Open market or private sale
$5,450 $18.23 p/Share
299 Reduced 0.05%
575,661 Ordinary Shares
Nov 25 2024
BUY
Exercise of conversion of derivative security
$1,746 $5.84 p/Share
299 Added 0.05%
575,960 Ordinary Shares
Nov 22 2024
SELL
Open market or private sale
$30,479 $18.24 p/Share
1,671 Reduced 0.29%
575,661 Ordinary Shares
Nov 22 2024
BUY
Exercise of conversion of derivative security
$9,758 $5.84 p/Share
1,671 Added 0.29%
577,332 Ordinary Shares
Nov 21 2024
SELL
Open market or private sale
$64,040 $18.24 p/Share
3,511 Reduced 0.61%
575,661 Ordinary Shares
Nov 21 2024
BUY
Exercise of conversion of derivative security
$20,504 $5.84 p/Share
3,511 Added 0.6%
579,172 Ordinary Shares
Nov 20 2024
SELL
Open market or private sale
$928,950 $16.89 p/Share
55,000 Reduced 8.72%
575,661 Ordinary Shares
Nov 13 2024
SELL
Open market or private sale
$585,380 $18.28 p/Share
32,023 Reduced 4.83%
630,661 Ordinary Shares
Nov 13 2024
BUY
Exercise of conversion of derivative security
$187,014 $5.84 p/Share
32,023 Added 4.61%
662,684 Ordinary Shares
Oct 23 2024
SELL
Open market or private sale
$39,709 $15.32 p/Share
2,592 Reduced 0.41%
630,661 Ordinary Shares
Oct 22 2024
SELL
Open market or private sale
$473,281 $15.67 p/Share
30,203 Reduced 4.55%
633,253 Ordinary Shares
Oct 21 2024
SELL
Open market or private sale
$350,839 $15.8 p/Share
22,205 Reduced 3.24%
663,456 Ordinary Shares
Sep 30 2024
SELL
Payment of exercise price or tax liability
$572,592 $15.79 p/Share
36,263 Reduced 5.02%
685,661 Ordinary Shares
Sep 20 2024
SELL
Open market or private sale
$909,150 $16.53 p/Share
55,000 Reduced 7.08%
721,924 Ordinary Shares
Sep 10 2024
SELL
Open market or private sale
$2,891,000 $16.52 p/Share
175,000 Reduced 18.38%
776,924 Ordinary Shares
Sep 10 2024
BUY
Exercise of conversion of derivative security
$1,022,000 $5.84 p/Share
175,000 Added 15.53%
951,924 Ordinary Shares
Aug 23 2024
SELL
Open market or private sale
$573,807 $12.3 p/Share
46,651 Reduced 5.66%
776,924 Ordinary Shares
Aug 22 2024
SELL
Open market or private sale
$6,188 $12.23 p/Share
506 Reduced 0.06%
823,575 Ordinary Shares
Aug 21 2024
SELL
Open market or private sale
$45,006 $12.25 p/Share
3,674 Reduced 0.44%
824,081 Ordinary Shares
Aug 20 2024
SELL
Open market or private sale
$51,362 $12.32 p/Share
4,169 Reduced 0.5%
827,755 Ordinary Shares
Jun 30 2024
SELL
Payment of exercise price or tax liability
$327,454 $9.03 p/Share
36,263 Reduced 4.18%
831,924 Ordinary Shares
Mar 31 2024
SELL
Payment of exercise price or tax liability
$409,771 $11.3 p/Share
36,263 Reduced 4.01%
868,187 Ordinary Shares

Also insider at

CLVT
CLARIVATE Plc Technology
SS

Saurabh Saha

Chief Executive Officer
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA